Bridging preclinical science to clinical design in the development of long-acting injectables: IQ Consortium Industry Perspectives
{{output}}
Long-acting injectables (LAIs) have been emerging as a transformative approach in drug delivery, enabling sustained therapeutic effects and improved patient compliance. However, the transition from preclinical innovation to successful clinical design and regul... ...
